Clal Biotechnology Industries Ltd.

TASE:CBI Voorraadrapport

Marktkapitalisatie: ₪55.8m

Clal Biotechnology Industries Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Avi Fischer

Algemeen directeur

₪586.0k

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOless than a year
Eigendom CEOn/a
Management gemiddelde ambtstermijn2.5yrs
Gemiddelde ambtstermijn bestuur7yrs

Recente managementupdates

Recent updates

Clal Biotechnology Industries (TLV:CBI) Is Carrying A Fair Bit Of Debt

Oct 09
Clal Biotechnology Industries (TLV:CBI) Is Carrying A Fair Bit Of Debt

The Market Doesn't Like What It Sees From Clal Biotechnology Industries Ltd.'s (TLV:CBI) Revenues Yet

Apr 18
The Market Doesn't Like What It Sees From Clal Biotechnology Industries Ltd.'s (TLV:CBI) Revenues Yet

Calculating The Fair Value Of Clal Biotechnology Industries Ltd. (TLV:CBI)

Jul 14
Calculating The Fair Value Of Clal Biotechnology Industries Ltd. (TLV:CBI)

Does Clal Biotechnology Industries (TLV:CBI) Have A Healthy Balance Sheet?

Jan 19
Does Clal Biotechnology Industries (TLV:CBI) Have A Healthy Balance Sheet?

Investors Shouldn't Be Too Comfortable With Clal Biotechnology Industries' (TLV:CBI) Robust Earnings

Mar 25
Investors Shouldn't Be Too Comfortable With Clal Biotechnology Industries' (TLV:CBI) Robust Earnings

Clal Biotechnology Industries (TLV:CBI) Seems To Use Debt Quite Sensibly

Mar 24
Clal Biotechnology Industries (TLV:CBI) Seems To Use Debt Quite Sensibly

Introducing Clal Biotechnology Industries (TLV:CBI), The Stock That Zoomed 121% In The Last Year

Feb 16
Introducing Clal Biotechnology Industries (TLV:CBI), The Stock That Zoomed 121% In The Last Year

What Kind Of Shareholders Own Clal Biotechnology Industries Ltd. (TLV:CBI)?

Jan 12
What Kind Of Shareholders Own Clal Biotechnology Industries Ltd. (TLV:CBI)?

Is Clal Biotechnology Industries (TLV:CBI) Using Too Much Debt?

Dec 07
Is Clal Biotechnology Industries (TLV:CBI) Using Too Much Debt?

CEO

Avi Fischer (68 yo)

less than a year

Tenure

₪586,000

Compensatie

Dr. Avraham Matityahu Fischer, also known as Avi, M.D., is Co-Managing Partner of Fischer Behar Chen Well Orion & Co. Dr. Fischer is Deputy CEO, Executive VP and Deputy Chairman of Idb Development Corporat...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Avraham Fischer
Chairman & CEOless than a year₪586.00kgeen gegevens
Liat Nissan
Chief Financial Officer2.1yrs₪975.00kgeen gegevens
Iris Sadeh
Accountant2.8yrsgeen gegevensgeen gegevens
Shiran Manor
General Counsel & Corporate Secretaryno datageen gegevensgeen gegevens
Etty Kliger
Vice President of Research & Development - MediWoundno data₪1.10mgeen gegevens
Lior Rosenberg
Vice President of Medical Technologies - MediWoundno data₪1.21mgeen gegevens
Arnon Aharon
Medical Director2.8yrsgeen gegevensgeen gegevens

2.5yrs

Gemiddelde duur

61.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van CBI wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.5 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Avraham Fischer
Chairman & CEO21.5yrs₪586.00kgeen gegevens
Yuval Yanai
External Independent Director8.9yrsgeen gegevensgeen gegevens
Gonen Bieber
Directorless than a yeargeen gegevensgeen gegevens
Gad Keren
Independent External Director4.8yrsgeen gegevensgeen gegevens
Gabriel Barabash
Director21.7yrsgeen gegevensgeen gegevens
Nufar Malovani
Director7yrsgeen gegevensgeen gegevens
Tomer Babai
Director6.9yrsgeen gegevensgeen gegevens

7.0yrs

Gemiddelde duur

68yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van CBI wordt beschouwd als ervaren (gemiddelde ambtstermijn 7 jaar).